MX2013007099A - Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia. - Google Patents

Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.

Info

Publication number
MX2013007099A
MX2013007099A MX2013007099A MX2013007099A MX2013007099A MX 2013007099 A MX2013007099 A MX 2013007099A MX 2013007099 A MX2013007099 A MX 2013007099A MX 2013007099 A MX2013007099 A MX 2013007099A MX 2013007099 A MX2013007099 A MX 2013007099A
Authority
MX
Mexico
Prior art keywords
bacterium
same
extracts
therapy
novel
Prior art date
Application number
MX2013007099A
Other languages
English (en)
Other versions
MX345124B (es
Inventor
Nathalie Castex-Rizzi
Thien Nguyen
Christine Libon
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MX2013007099A publication Critical patent/MX2013007099A/es
Publication of MX345124B publication Critical patent/MX345124B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una cepa bacteriana novedosa y caracterizada del agua freática. La invención también se refiere a extractos bacterianos y al uso terapéutico de la misma, en forma notable en el contexto del tratamiento de inflamaciones.
MX2013007099A 2010-12-22 2011-12-22 Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia. MX345124B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1061082A FR2969658B1 (fr) 2010-12-22 2010-12-22 Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
PCT/EP2011/073749 WO2012085183A1 (en) 2010-12-22 2011-12-22 Novel bacterium and extracts of said bacterium and the use of same in therapy

Publications (2)

Publication Number Publication Date
MX2013007099A true MX2013007099A (es) 2013-08-08
MX345124B MX345124B (es) 2017-01-17

Family

ID=45554602

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007099A MX345124B (es) 2010-12-22 2011-12-22 Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.

Country Status (13)

Country Link
US (1) US9486486B2 (es)
EP (1) EP2655668B1 (es)
JP (1) JP6152515B2 (es)
KR (1) KR102145635B1 (es)
CN (1) CN103379909B (es)
AU (1) AU2011347255B2 (es)
BR (1) BR112013016019A2 (es)
CA (1) CA2822717C (es)
FR (1) FR2969658B1 (es)
MX (1) MX345124B (es)
RU (1) RU2615140C2 (es)
WO (1) WO2012085183A1 (es)
ZA (1) ZA201304460B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013190106A1 (en) * 2012-06-21 2013-12-27 Pierre Fabre Medicament Use of a live bacterium for the treatment of intestinal inflammatory disorders
FR3065009B1 (fr) * 2017-04-06 2020-11-27 Fabre Pierre Dermo Cosmetique Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr) * 2018-06-01 2020-12-04 Fabre Pierre Dermo Cosmetique Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009032A1 (fr) * 1995-09-07 1997-03-13 L'oreal Utilisation d'un extrait d'une bacterie filamenteuse non photosynthetique et composition le contenant
EP1495039A4 (en) * 2002-03-20 2006-07-26 Univ Emory MUTANTS OF NEISSERIA, LIPOOLIGOSACCHARIDES AND IMMUNOGENIC COMPOSITIONS
GB0321615D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Improvements in vaccination
WO2005030133A2 (en) * 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
BRPI0808333B8 (pt) * 2007-03-05 2021-05-25 Om Pharma extrato bacteriano para doenças respiratórias e processo para sua preparação
FR2918884B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
US20090297552A1 (en) * 2008-04-25 2009-12-03 Aderem Alan A Flagellin polypeptide vaccines
EP2274320A1 (en) * 2008-04-25 2011-01-19 ID Biomedical Corporation of Quebec Methods for preparing immunogenic compositions
SI22889A (sl) * 2008-10-28 2010-04-30 Kemijski inštitut Himerni flagelini za cepiva
WO2010135704A2 (en) * 2009-05-22 2010-11-25 Institute For Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation

Also Published As

Publication number Publication date
US9486486B2 (en) 2016-11-08
AU2011347255B2 (en) 2017-02-02
ZA201304460B (en) 2014-02-26
EP2655668B1 (en) 2018-05-30
EP2655668A1 (en) 2013-10-30
FR2969658B1 (fr) 2014-10-17
MX345124B (es) 2017-01-17
KR20140114268A (ko) 2014-09-26
KR102145635B1 (ko) 2020-08-18
BR112013016019A2 (pt) 2017-03-07
US20130296222A1 (en) 2013-11-07
CN103379909B (zh) 2016-05-04
RU2013132894A (ru) 2015-01-27
CA2822717C (en) 2019-03-12
WO2012085183A1 (en) 2012-06-28
AU2011347255A1 (en) 2013-07-04
CN103379909A (zh) 2013-10-30
JP6152515B2 (ja) 2017-06-28
RU2615140C2 (ru) 2017-04-04
FR2969658A1 (fr) 2012-06-29
CA2822717A1 (en) 2012-06-28
JP2014503541A (ja) 2014-02-13

Similar Documents

Publication Publication Date Title
TN2012000414A1 (en) Forms of rifaximin and uses thereof
MX350234B (es) Compuestos de enlace especificos de bacterias gram-positivas.
IN2012DN01920A (es)
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX2010008137A (es) Bacterias no patogenas y/o atenuadas capaces de inducir apoptosis en macrofagos, proceso de fabricacion y su usos.
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
AU2011328009A8 (en) Compounds and methods for treating pain
MX2009009079A (es) Anticuerpos anti-il-23p19 de ingenieria.
MX2009009080A (es) Anticuerpos anti-interleucina-23p19 manipulados por ingenieria genetica.
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
IN2012DN00624A (es)
MX2014000066A (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
UA118339C2 (uk) Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
WO2011153460A3 (en) Therapeutic amoeba and uses thereof
MX345124B (es) Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
PT2836612T (pt) Nova estirpe de pseudomonas fluorescens e o uso da mesma no controlo biológico das doenças bacterianas ou fúngicas
EA201291440A1 (ru) Пробиотические штаммы для применения при повышении трансэпителиального сопротивления
WO2011019636A3 (en) Methods and compositions for the treatment of cancers and pathogenic infections
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
UA35047U (ru) Способ проведения оздоровительной гимнастики
MX2012000625A (es) Compuestos de enlace especificos de bacterias gram-positivas.

Legal Events

Date Code Title Description
FG Grant or registration